InvestorsHub Logo
Followers 85
Posts 9363
Boards Moderated 1
Alias Born 10/12/2009

Re: None

Tuesday, 12/13/2011 12:00:06 PM

Tuesday, December 13, 2011 12:00:06 PM

Post# of 923
YMI

This statement suggest that YMI is undervalued by 10x.....

1.66 x 10 = $16.60?

maybe?

Based on the positive anemia response data released Monday, the current valuation gap between Incyte ($1.8 billion market cap) and YM Bio ($170 million market cap) is way too big even considering '387 is two or three years behind in clinical development. "It's a drug," said Crespi Monness Hardt analyst (and YM Bio supporter) Avik Roy, referring to '387.


Harleyman!